SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Linda Kaplan who wrote (6200)2/16/1999 3:22:00 PM
From: Linda Kaplan  Respond to of 7041
 
Correction: The numbers weren't units but dollars, so they had $163,000 income for the three quarters, but all in the first quarter, no additional sales in the second or third quarter they were able to sell in Mexico. Whoever keeps saying that Mexico sales are "great" is not even remotely accurate.

Linda



To: Linda Kaplan who wrote (6200)2/16/1999 6:43:00 PM
From: Bill Wexler  Respond to of 7041
 
The Zonagen fraud announces losses and zero sales of its ineffective drug.

biz.yahoo.com

No matter how many times they squeeze this crud, no matter how many time the whores at Oppenheimer issue phony reports, this stock will eventually and inevitably trade in the low single digits.